1. Home
  2. JSPR vs AVD Comparison

JSPR vs AVD Comparison

Compare JSPR & AVD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Jasper Therapeutics Inc.

JSPR

Jasper Therapeutics Inc.

SELL

Current Price

$14.35

Market Cap

26.3M

Sector

Health Care

ML Signal

SELL

Logo American Vanguard Corporation ($0.10 Par Value)

AVD

American Vanguard Corporation ($0.10 Par Value)

HOLD

Current Price

$0.77

Market Cap

28.4M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
JSPR
AVD
Founded
2018
1969
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Agricultural Chemicals
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
26.3M
28.4M
IPO Year
2019
1995

Fundamental Metrics

Financial Performance
Metric
JSPR
AVD
Price
$14.35
$0.77
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
321.1K
★ 440.1K
Earning Date
11-27-2026
11-09-2026
Dividend Yield
N/A
N/A
EPS Growth
19.22
★ 61.11
EPS
★ N/A
N/A
Revenue
N/A
★ $515,114,000.00
Revenue This Year
N/A
$7.74
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$0.32
$0.81
52 Week High
$17.03
$5.53

Technical Indicators

Market Signals
Indicator
JSPR
AVD
Relative Strength Index (RSI) 80.68 22.92
Support Level $0.64 N/A
Resistance Level $17.03 $1.20
Average True Range (ATR) 1.05 0.10
MACD 1.15 0.01
Stochastic Oscillator 79.63 0.39

Price Performance

Historical Comparison
JSPR
AVD

About JSPR Jasper Therapeutics Inc.

Jasper Therapeutics Inc is a clinical-stage biotechnology company focused on developing therapeutics targeting mast cell driven diseases such as Chronic Spontaneous Urticaria (CSU), Chronic Inducible Urticaria (CIndU) and asthma. The company's lead product candidate, briquilimab, is a monoclonal antibody designed to block stem cell factor (SCF) from binding to and signaling through the CD117 (KIT) receptor on mast and stem cells. The company has a single operating and reportable segment, which is the research and development of therapeutic products in the fields of chronic urticaria and asthma.

About AVD American Vanguard Corporation ($0.10 Par Value)

American Vanguard Corp is a United States-based diversified specialty and agricultural products company. The company is a manufacturer of specialty solutions that develops and markets safe synthetic, biological, and biorational products for agricultural, commercial, and consumer uses. These chemicals include insecticides, fungicides, herbicides, molluscicides, growth regulators, and soil fumigants, which are marketed in liquid, powder, and granular forms.

Share on Social Networks: